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ABSTRACT
Background: Mexican Americans and non-Hispanic blacks have higher stroke recurrence rates
and lower rates of secondary stroke prevention than non-Hispanic whites. As a potential explana-
tion for this disparity, we assessed racial/ethnic differences in access to physician care and med-
ications in a national sample of US stroke survivors.
Methods: Among all 4,864 stroke survivors aged 45 years who responded to the National
Health Interview Survey years 2000–2006, we compared access to care within the last 12
months by race/ethnicity before and after stratification by age (45–64 years vs65 years). With
logistic regression, we adjusted associations between access measures and race/ethnicity for
sex, comorbidity, neurologic disability, health status, year, income, and health insurance.
Results: Among stroke survivors aged 45–64 years, Mexican Americans, non-Hispanic blacks,
and non-Hispanic whites reported similar rates of no generalist physician visit (approximately
15%) and inability to afford medications (approximately 20%). However, among stroke survivors
aged 65 years, Mexican Americans and blacks, compared with whites, reported greater fre-
quency of no generalist visit (15%, 12%, 8%; p0.02) and inability to afford medications (20%,
11%, 6%; p  0.001). Mexican Americans and blacks more frequently reported no medical spe-
cialist visit (54%, 49%, 40%; p  0.001) than did whites and rates did not differ by age. Full
covariate adjustment did not fully explain these racial/ethnic differences.
Conclusions: Among US stroke survivors at least 65 years old, Mexican Americans and blacks
reported worse access to physician care and medications than whites. This reduced access may
lead to inadequate risk factor modification and recurrent stroke in these high-riskminority groups.
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GLOSSARY
AMI acute myocardial infarction; CRN cost-related nonadherence; NHIS National Health Interview Survey.
Racial/ethnic disparities in stroke and its secondary prevention constitute substantial health
and economic concerns for medical and public health systems.1 Non-Hispanic blacks and
Hispanics, particularly Mexican Americans, have markedly higher incidence and prevalence of
stroke than non-Hispanic whites, a difference that continues until age 75–85 years.2,3 More-
over, blacks and Mexican Americans have increased risk of recurrent stroke4,5 (which is more
disabling and costly compared with first stroke6). Despite greater recurrent stroke risk, minor-
ity stroke survivors have lower rates of secondary stroke prevention.7-10
Reduced access to physicians and medications may prevent minority stroke survivors from
receiving adequate secondary stroke prevention. Secondary stroke prevention requires access to
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care, often both generalist and specialist phy-
sician care, and to medications, to treat modi-
fiable risk factors, such as hypertension and
diabetes mellitus. Among US stroke survivors,
blacks and Hispanics may have reduced access
to stroke preventive care because they have
lower median household income, have less ac-
cess to high-quality health care, and are more
frequently uninsured.11 Few studies have as-
sessed racial/ethnic differences in access to
ambulatory physician care or medication af-
fordability among stroke survivors. Little is
known regarding racial/ethnic differences in
access to care for stroke survivors across the
United States.
We examined racial/ethnic differences in
access to physician care and medications, as
well as other barriers to care, among non-
Hispanic black, Mexican American, and
non-Hispanic white community-dwelling
stroke survivors using data from a recent
nationally representative, population-based
survey. We focus on Mexican Americans
because they are the largest subgroup of
Hispanics, in turn the largest minority pop-
ulation in the United States, they have been
shown to have higher recurrent stroke rates,
and the remaining surveyed Hispanic sub-
groups were small and heterogeneous.
METHODS In this cross-sectional study, we compared access
to care by race/ethnicity before and after stratification by age
(45–64 years vs 65 years) among stroke survivors who re-
sponded to the National Health Interview Survey (NHIS) from
years 2000 to 2006.
Study population. The NHIS is a continuing, in-person
household survey of the civilian, noninstitutionalized US popu-
lation conducted annually by the National Center for Health
Statistics.12 NHIS adult survey years 2000 to 2006 used similar
survey designs and data collection methods and had final re-
sponse rates of 70%–80%.12
Stroke survivors were identified as respondents who answered
yes to the question, “Have you ever been told by a doctor or other
health professional that you had a stroke?” The 2000 to 2006NHIS
samples from all US states and the District of Columbia and was
designed to produce population-based estimates for the entire
United States.12 NHIS oversamples black and Hispanic persons at
approximate rates of 1.5:1 for blacks and 2:1 for Hispanics.12 To
increase the proportion of elderly adults who are black or Hispanic,
any black or Hispanic adult aged 65 years was given twice the
chance of being selected as any other adult in the family starting
with the 2006NHIS.12 We combined self-reported race and ethnic-
ity to create 3 racial/ethnic groups: non-Hispanic whites (whites),
non-Hispanic blacks (blacks), and Hispanic Mexican Americans
(Mexican Americans). Data were obtained from the Minnesota
Population Center and State Health Access Data Assistance Center
(Integrated Health Interview Survey: Version 1.0; Minneapolis:
University of Minnesota, 2006; http://ihis.us).
Outcome measures. The 3 outcomes, measured within the
past 12 months, were report of a visit to a generalist (general
practice, family medicine, or internal medicine) physician, re-
port of a visit to a medical specialist (other than obstetrician/
gynecologist, psychiatrist, or ophthalmologist), and the inability
to afford medications (“Was there any time when you needed
prescription medicines but didn’t get [them] because you
couldn’t afford [them]?”).
Statistical analysis. Health care access variables and outcome
measures were compared between racial/ethnic groups using 2
test or t test, and US population estimates were calculated. Co-
variates were selected using clinical observation, literature review,
and the Andersen Behavioral Model framework,13 which defines
key factors (predisposing, enabling, and need-based) that impact
health behaviors (i.e., having physician visits or purchasing med-
ications) and outcomes. Predisposing factors relate to demo-
graphics and social structure and included age, sex, and
education. Enabling factors refer to personal/family resources or
health care access and included having a usual place for medical
care, annual household income, lack of transportation delaying
care, and health insurance. Need-based factors relate to perceived
and evaluated health and included self-reported health status,
neurologic disability due to stroke, and comorbidity. A comor-
bidity score was calculated by assigning 1 point for the presence
of each of 6 major health conditions (hypertension, coronary
heart disease, diabetes mellitus, emphysema, chronic kidney dis-
ease, and heart condition or disease) resulting in a maximum
score of 6.14 Neurologic disability attributable to stroke was de-
fined as stroke causing the adult respondent to have difficulty
with 1 specific functional activities (e.g., walk a quarter mile,
lift/carry 10 pounds). Given general qualification for Medicare
health insurance at age 65 and our previous research showing
that age modifies access to physician care and medications
among stroke survivors,15 we examined frequencies of health in-
surance and access measures by race/ethnicity among younger
(aged 45–64 years) and older (aged65 years) stroke survivors.
Multivariable logistic regression analyses, stratified by the
two age groups, examined the adjusted associations between ra-
cial/ethnic groups and the 3 outcome measures. We performed
incremental regression models to examine the effect of sequential
addition (i.e., forced entry) of predisposing factors, followed by
enabling factors and then need-based factors. Annual household
income and educational attainment were highly correlated so we
included income and omitted education from the final models.
Two covariates, usual place of care and lack of transportation,
were excluded due to a lack of statistical contribution to the
models. All of the analyses used SAS-callable SUDAAN version
9.01 (Research Triangle Institute, Research Triangle Park, NC)
to obtain proper variance estimations that accounted for the
complex NHIS sampling design and results that were weighted
to reflect national population estimates.
Standard protocol approvals, registrations, and patient
consents. The Ohio State University institutional review board
approved the project.
RESULTS We identified 4,864 stroke survivors
aged 45 years representing an estimated 4.3 mil-
lion US stroke survivors (191,000 Mexican Ameri-
cans [4%], 597,000 blacks [14%], 3.5 million whites
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[82%]). Mexican Americans (n  319) and blacks
(n  896) were more likely than whites (n  3649)
to report high school education and annual house-
hold income $20,000 (table 1). Mexican Ameri-
cans were more likely to be born outside the United
States than blacks or whites. Mexican Americans and
Table 1 Characteristics of stroke survivors by race/ethnicity: National Health Interview Survey, 2000–2006a
Variable
Mexican Americans Non-Hispanic blacks Non-Hispanic whites
No. (%)
Population
estimate No. (%)
Population
estimate No. (%)
Population
estimate
No. (%) 319 (4) 191,280 896 (14) 597,438 3,649 (82) 3,492,204
Mean age, y (standard error) 64.98 (0.81)b NA 65.36 (0.46)b NA 70.42 (0.22) NA
Age 45–64 y 145 (47)b 90,504 395 (48)b 284,115 1,006 (30) 1,055,797
Female sex 169 (48) 90,883 544 (55) 328,841 2,080 (52) 1,809,326
Annual household income<$20,000 179 (48)b 83,766 541 (56)b 297,768 1,471 (35) 1,114,815
Education< high school 215 (67)b 122,008 418 (47)b 270,293 1,071 (30) 1,021,699
Born outside United States and
US territories
112 (40)b 75,459 20 (3) 16,488 165 (4) 154,900
Low health statusd 215 (66)b 125,446 595 (69)b 407,127 1,837 (52) 1,816,449
Barriers to care
Delayedmedical care because couldn’t
get appointment soon
27 (8) 15,329 37 (3)b 19,528 207 (5) 186,757
Delayedmedical care due to cost 45 (13) 25,745 133 (13)b 79,592 386 (10) 340,723
Delayedmedical care because lacked
transportation
32 (10)b 19,178 59 (6)c 33,220 160 (4) 124,832
Delayedmedical care because wait
too long in doctor’s office
38 (11)c 21,230 60 (6) 34,095 205 (6) 193,142
No usual place for medical care 18 (5) 10,245 31 (3) 17,952 105 (3) 101,956
No health insurance 36 (12)b 23,303 54 (6)b 37,988 106 (3) 107,228
Comorbidities
Coronary heart disease 99 (32) 60,352 298 (35) 208,552 1,378 (39) 1,335,243
Diabetes mellitus 149 (47)b 89,450 321 (36)b 213,860 863 (25) 864,999
Hypertension 233 (76) 145,990 768 (87)b 513,850 2,606 (71) 2,485,465
Emphysema 22 (6)b 12,022 46 (5)b 28,602 406 (11) 393,163
Heart condition/disease 69 (19)b 35,552 195 (20)b 119,784 1,131 (32) 1,094,766
Chronic kidney disease 39 (12) 23,613 105 (13)b 75,383 316 (9) 305,416
Mean comorbidity score
(standard error)e
1.92 (0.08) NA 1.94 (0.05) NA 1.86 (0.02) NA
>2 Comorbidities 187 (60) 114,937 532 (59) 355,413 2,025 (56) 1,956,746
Neurologic disability due to stroke 122 (38) 72,026 413 (47)b 279,001 1,132 (31) 1,090,238
Access to physician care and
medications
No generalist physician visit 41 (15)c 28,156 119 (14)b 82,759 347 (10) 336,232
Nomedical specialist visit 167 (54)b 101,716 439 (49)b 287,752 1,526 (40) 1,395,294
No general doctor or medical
specialist visit
28 (10)c 18,891 82 (9)b 50,329 198 (5) 177,763
Inability to afford medications 61 (18)b 34,308 145 (16)b 91,494 369 (10) 332,604
a Data source: National Center for Health Statistics (2000–2006). All percentages are weighted according to sampling fractions used by the National
Health Interview Survey. Population estimates were calculated using SAS-callable SUDAAN software, version 9.00.1 (Research Triangle Institute) to
obtain proper variance estimations that accounted for the complex sampling design of the National Health Interview Survey and results that were
weighted to reflect national population estimates. Observationswithmissing valueswere excluded from the denominator for the computation of frequency
when the covariate wasmissing; thus, the percentages in the table cannot be reproduced exactly by taking the overall N in the first row as the denominator
for each cell in a column.
b p 0.01 compared with non-Hispanic whites.
c p 0.05 compared with non-Hispanic whites.
d Low self-reported health status defined as poor or fair on 5-point Likert scale.
e Comorbidity score was calculated using a composite score based on 6 major health conditions: hypertension, coronary heart disease, diabetes mellitus,
emphysema, heart condition/disease, and chronic kidney disease.
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blacks reported similar but higher than whites’ rates
of low health status. The prevalence of diabetes was
highest in Mexican Americans and of hypertension
highest in blacks. The comorbidity score (mean 1.9)
was similar across racial/ethnic groups.
Racial/ethnic differences in barriers to medical care among
US stroke survivors. Overall, Mexican Americans and
blacks were significantly more likely than whites to have
lack of transportation delaying medical care and no
health insurance (table 1). Among those aged 45–64
years, rates of no health insurance were 17% for Mexi-
can Americans (pvs whites  0.03), 12% for blacks
(pvs whites 0.15), and 9% for whites; however, among
those aged65 years, rates of no health insurance were
8% for Mexican Americans (pvs whites 0.05), 2% for
blacks (pvs whites 0.19), and 0.6% for whites. Among
uninsured stroke survivors, 60% ofMexican Americans
were foreign-born compared with 2% of blacks and
11% of whites (p  0.001). Blacks more frequently
reported delaying medical care due to cost than whites,
whereas Mexican Americans more commonly reported
delaying medical care because of long wait in the doc-
tor’s office.
Racial/ethnic differences in access to physician care
and medications among US stroke survivors. Mexican
Americans and blacks, compared with whites, more
often reported no generalist visit, no medical special-
ist visit, no generalist or medical specialist visit, and
the inability to afford medications in the past 12
months (table 1). Stratification by age revealed that
racial/ethnic differences in no generalist visit and the
inability to afford medications were present among
those65 years old but absent in those 45–64 years
old; conversely, racial/ethnic differences in no spe-
cialist visit did not differ by age (figure). Compared
with younger stroke survivors, older stroke survivors
had lower frequency of no generalist visit for whites
only (14% vs 8%; p  0.01) and less difficulty af-
fording medications for whites (19% vs 6%; p 
0.01) and blacks (21% vs 11%; p  0.01) but not
Mexican Americans (17% vs 20%; p  0.61).
Effect of adjustment for demographic, socioeconomic,
and clinical characteristics. Among older stroke survi-
vors, greater odds of no generalist visit were seen for
blacks and there was a trend toward statistical signif-
icance for Mexican Americans after full adjustment.
Greater odds of inability to afford medications were
seen for Mexican Americans and there was a trend
toward statistical significance for blacks (table 2). For
both age groups, Mexican Americans and blacks had
significantly greater odds of no specialist visit after
adjustment. Regression models were not constructed
for the combined outcome of no generalist physician
or medical specialist visit because of insufficient sam-
ple size.
Figure Access to physician care andmedications by race/ethnicity and age: National Health Interview
Survey, 2000–2006*
*Data source: National Center for Health Statistics (2000–2006). †p 0.05 compared with non-Hispanic whites. ‡p 0.01
compared with non-Hispanic whites. **p 0.07.
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Given the magnitude of the odds ratios for no
health insurance predicting lack of physician visits or
inability to afford medications (point estimates of the
odds ratios ranged from 2.7 to 8.8 in table 2) and the
unexpectedly higher disparities in health insurance
for the older group, we also compared unadjusted
odds ratios, fully adjusted odds ratios (full models in
table 2), and models adjusted for all covariates in
table 2 except health insurance (table 3). We found
that adjustment for demographics and comorbidity
reduced racial/ethnic differences in inability to afford
medications. Further adjustment for health insur-
ance attenuated the odds of no generalist visit and
inability to afford medications for Mexican Ameri-
cans but not blacks.
DISCUSSION In this recent nationally representa-
tive sample of stroke survivors, non-Hispanic blacks
and Mexican Americans aged 65 years or older re-
ported less access to generalist and specialist physi-
cian care and to medications than similarly aged
non-Hispanic whites. Among those 45–64 years old,
these differences were present only for specialist care.
Comorbidity, health insurance, or income did not
fully explain observed racial/ethnic differences in ac-
cess to physician care and medications. Despite equal
or greater need for medical care with higher preva-
lence rates of stroke risk factors, such as hypertension
or diabetes, minority stroke survivors also had in-
creased frequency of additional barriers to care in-
cluding lack of transportation delaying care, income
$20,000, and, particularly for Mexican Americans,
no health insurance. Strikingly, although prevalence
of insurance was higher for each racial/ethnic group
in the Medicare age range than for the younger
group, racial/ethnic differences in health insurance
were more pronounced in those above age 65.
Among all covariates, lack of health insurance con-
ferred the highest adjusted odds for reduced access in
both age groups.
Although some16,17 but not all studies18 have
shown less access to specialist (neurologist) care for
minority stroke patients in the emergency depart-
ment or hospital setting, few studies have assessed
racial/ethnic differences in more general access mea-
sures and in a population-based fashion. Among US
veterans hospitalized with ischemic stroke, outpa-
tient utilization of both general medicine and neurol-
ogy in the VA health system was lower for whites
compared with blacks, although non-VA Medicare
health care utilization was not captured and may
have been higher among the older whites.19 In the
Brain Attack Surveillance in Corpus Christi project,
Mexican American stroke patients (mean age, 70
years) more frequently lacked a primary care physi-
cian compared with non-Hispanic whites (mean age,
75 years); however, the ethnic differences in access to
primary care were attenuated after adjustment for
age, sex, education, and insurance.20 We found that
black and Mexican American stroke survivors had
greater odds of no medical specialist visit and, among
Table 2 Adjusted odds ratios (95% confidence intervals) for predictors of reduced access to physician care andmedications: National
Health Interview Survey, 2000–2006a
Variable
No generalist physician visit Nomedical specialist visit Inability to afford medications
Age 45–64 y
(n 1,418)
Age 65 y
(n 2,957)
Age 45–64 y
(n 1,414)
Age 65 y
(n 2,955)
Age 45–64 y
(n 1,416)
Age 65 y
(n 2,962)
Mexican American 1.00 (0.50–2.01) 2.04 (0.97–4.30)b 1.97 (1.19–3.25)c 1.70 (1.15–2.52)c 0.61 (0.34–1.12) 2.39 (1.46–3.90)c
Non-Hispanic black 1.24 (0.79–1.95) 1.96 (1.32–2.92)c 1.51 (1.11–2.06)c 1.60 (1.25–2.05)c 0.78 (0.53–1.14) 1.43 (0.96–2.15)d
Non-Hispanic white 1.00 1.00 1.00 1.00 1.00 1.00
Female sex 0.93 (0.64–1.34) 1.06 (0.77–1.47) 0.94 (0.73–1.22) 1.17 (0.97–1.41) 1.92 (1.39–2.64)c 1.42 (1.01–1.99)c
Comorbidity score 0.81 (0.67–0.97)c 0.74 (0.64–0.84)c 0.78 (0.69–0.87)c 0.67 (0.62–0.73)c 1.25 (1.11–1.42)c 1.30 (1.14–1.48)c
Neurologic disability due to
stroke
0.74 (0.48–1.13) 0.64 (0.46–0.89)c 0.80 (0.61–1.05) 1.09 (0.90–1.33) 0.94 (0.68–1.31) 0.93 (0.67–1.28)
Low health status 0.72 (0.46–1.14) 1.08 (0.78–1.50) 0.56 (0.42–0.75)c 0.75 (0.62–0.90)c 2.36 (1.61–3.47)c 2.37 (1.65–3.41)c
Survey year (2000 referent) 1.00 (0.91–1.11) 0.96 (0.89–1.03) 0.96 (0.90–1.03) 0.99 (0.95–1.03) 1.07 (0.99–1.17) 1.04 (0.96–1.12)
Annual household income
<$20,000
1.27 (0.87–1.86) 1.11 (0.79–1.55) 1.28 (0.97–1.68)d 1.52 (1.28–1.82)c 1.96 (1.40–2.74)c 2.92 (2.05–4.17)c
No health insurance 2.77 (1.76–4.37)c 3.07 (0.56–16.73) 2.76 (1.83–4.17)c 8.80 (2.72–28.41)c 6.62 (4.31–10.14)c 5.98 (2.20–16.30)c
R2 for dependent variable 0.038 0.019 0.089 0.084 0.130 0.055
aData source: National Center for Health Statistics (2000–2006). Each column represents onemodel. Models adjusted for race/ethnicity, sex, comorbidity
score, neurologic disability due to stroke, health status, survey year, health insurance, and household income.
b p 0.06.
c 95% confidence intervals not containing 1. Observations with missing data were excluded from the regression models.
d p 0.08.
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blacks aged 65 years or older, no generalist physician
visit, after adjusting for comorbidity, socioeconomic
factors, and health insurance. Our finding of a non-
significant 2.04 greater odds in fully adjusted no gen-
eralist visit between Mexican Americans and whites
may be due to small sample size of Mexican Ameri-
cans or may reflect a true attenuation of the associa-
tion between Hispanic ethnicity and no generalist
visit by health insurance. In our earlier study assess-
ing age-related differences in access to care of US
stroke survivors in NHIS years 1998–2002, we
found that black race was associated with lack of
medical specialist visit but not with lack of generalist
visit, perhaps owing to smaller sample size, reduced
power to detect racial differences, and confounding
by ethnicity and time.15
Potential causes of racial/ethnic disparities in ac-
cess to or use of physician care include differences in
socioeconomic status, health care access and utiliza-
tion, and community resources, differences that may
not be fully captured by income and insurance.11,21
Previous US research has found that differences in
insurance, income, and available safety net services
explain most differences (80%) in access to physi-
cian care between Hispanics and whites but explain
less of the access disparities between blacks and
whites.21 Lower incomes and education levels of mi-
nority stroke survivors may be associated with
broader health care access problems. Even in a system
of universal health coverage, higher incomes and ed-
ucation levels are associated with significantly greater
likelihood of referral to a cardiologist following dis-
charge from acute myocardial infarction (AMI) hos-
pitalization.22 In addition, physician practices and
health care systems serving minority populations in
the United States may have greater problems access-
ing specialist care and delivering high-quality
care.23,24
Our findings are consistent with previous research
in older US adults with chronic health conditions
showing greater odds of cost-related nonadherence to
medication among blacks and Hispanics compared
with whites even after adjusting for demographic fac-
tors, comorbidity, or prescription drug coverage.25 In
previous studies of US stroke survivors, we obtained
conflicting results for the association of being black
with inability to afford medications. The study of
age-related differences in medication access found an
absence of association possibly due to insufficient
power and confounding by Hispanic ethnicity.15 In
the study of regional differences in medication ac-
cess, black women but not black men were more
likely to be unable to afford medications after adjust-
ment for income and insurance, possibly due to ef-
Table 3 Odds ratios (95% confidence intervals) for access to physician care andmedications, by age group, Mexican American and non-
Hispanic black vs non- Hispanic white, unadjusted, adjusted for all covariates except health insurance, and fully adjusted:
National Health Interview Survey, 2000–2006a
No generalist physician visit Nomedical specialist visit Inability to afford medications
Age 45–64 y
(n 1,418)
Age 65 y
(n 2,957)
Age 45–64 y
(n 1,414)
Age 65 y
(n 2,955)
Age 45–64 y
(n 1,416)
Age 65 y
(n 2,962)
Unadjusted
Mexican American 1.09 (0.60–1.98) 2.06 (1.11–3.82)b 1.91 (1.23–2.97)b 1.70 (1.14–2.54)b 0.87 (0.50–1.50) 4.07 (2.33–7.12)b
Non-Hispanic black 1.17 (0.77–1.76) 1.66 (1.15–2.39)b 1.37 (1.03–1.82)b 1.52 (1.22–1.90)b 1.15 (0.85–1.57) 2.00 (1.37–2.93)b
R2 for dependent variable 0.0005 0.004 0.009 0.006 0.0008 0.010
Partially adjusted: all except
health insurance
Mexican American 1.10 (0.57–2.12) 2.31 (1.20–4.46)b 2.05 (1.25–3.36)b 1.88 (1.27–2.78)b 0.81 (0.44–1.49) 2.89 (1.51–5.56)b
Non-Hispanic black 1.30 (0.84–2.02) 2.00 (1.35–2.97)b 1.55 (1.13–2.10)b 1.60 (1.25–2.05)b 0.86 (0.60–1.22) 1.45 (0.97–2.16)c
R2 for dependent variable 0.023 0.018 0.070 0.077 0.077 0.051
Fully adjusted: includes
health insurance
Mexican American 1.00 (0.50–2.01) 2.04 (0.97–4.30)d 1.97 (1.19–3.25)b 1.70 (1.15–2.52)b 0.61 (0.34–1.12) 2.39 (1.46–3.90)b
Non-Hispanic black 1.24 (0.79–1.95) 1.96 (1.32–2.92)b 1.51 (1.11–2.06)b 1.60 (1.25–2.05)b 0.78 (0.53–1.14) 1.43 (0.96–2.15)e
R2 for dependent variable 0.038 0.019 0.089 0.084 0.130 0.055
a Data source: National Center for Health Statistics (2000–2006). Each 2 contiguous cells in a column represent a separate model. Unadjusted models
adjusted for race/ethnicity only. Partially adjusted models also included sex, comorbidity score, neurologic disability due to stroke, health status, survey
year, and household income. Fully adjusted models also included health insurance.
b 95% confidence intervals not containing 1. Observations with missing data were excluded from the regression models.
c p 0.07.
d p 0.06.
e p 0.08.
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fect modification by gender and age.14 Our finding
of a nonsignificant 1.45 greater odds in adjusted in-
ability to afford medications for blacks vs whites, in
the present study, may be due to decreased power or
may reflect a true attenuation of the association be-
tween being black and inability to afford medications
by demographics and comorbidity. Demographics
and comorbidity and also health insurance explained
some but not all of the difference in inability to af-
ford medications between Mexican Americans and
whites.
The reasons for greater difficulty affording medi-
cations among older minority stroke survivors are
uncertain but may include unmeasured racial/ethnic
differences in socioeconomic status.25 Given the need
for secondary stroke prevention and the frequency of
stroke-related conditions and comorbidities, stroke
survivors have a high burden and cost of medication.
In the observational CAReS study, stroke survivors
aged 50 years or older were discharged home from
rehabilitation with an average of 11.3 medications
(range 3–27).26 In the same cohort, the monthly cost
of the 10 most common medications prescribed at
discharge was $800 (monthly average wholesale
price, 2008).26 In this 2000–2006 study, we found
that, among US stroke survivors aged 45 years or
older, about 1 in 5 Mexican Americans, 1 in 6 blacks,
and 1 in 10 whites had cost-related nonadherence
(CRN) to medication within the last 12 months. Al-
though the NHIS asks only about CRN to any med-
ication, a survey of middle-aged and elderly adults
that specifically assessed CRN to stroke medication
found that 13% of US stroke survivors reported
CRN to stroke medication ever in the past year and
8% reported CRN to stroke medication at least
monthly, numbers consistent with our findings.27
Reduced access to ambulatory physician care and
medications following stroke potentially leads to
poor quality of care and adverse health outcomes.
Lack of physician follow-up after stroke has been as-
sociated with lower rates of secondary stroke preven-
tive therapy28 and higher risk of death, even after
adjusting for demographics and comorbidity.19 Al-
though there is not information regarding the impact
of CRN to medication on health outcomes in co-
horts of stroke patients only, studies in middle-aged
and elderly adults with preexisting cardiovascular dis-
ease including stroke found that CRN to medication
was associated with greater odds of nonfatal stroke or
AMI,29 angina,29 and hospitalization.30 In a study of a
related cardiovascular disease, AMI, financial barriers
to health care services or medications were associated
with suboptimal recovery including more angina,
higher risk of rehospitalization, and poorer quality of
life.31 The provision of affordable or immediate
Medicare insurance to uninsured stroke survivors
would be expected to improve access to medical care,
including physician visits32 and medications,33 and
may result in substantial health gains and subsequent
reductions in health care costs.34 Full prescription
drug coverage of secondary preventive therapies for
poststroke patients after hospital discharge, currently
under study for post-AMI patients,35 may prove cost-
effective.36 In addition to health insurance and pre-
scription drug coverage, increased resources and
insurance reimbursements for primary care providers
in high-minority practices are needed to improve the
quality of care, including care coordination and abil-
ity to obtain specialty care, for complex ambulatory
poststroke patients.24
Our study has several limitations. Given the ob-
servational study design, we cannot infer causation
from observed associations. Several factors, including
provider characteristics, metropolitan status, and
stroke features (type, severity, or timing), could not
be assessed adequately. These NHIS data, including
stroke history, are self-reported and subject to recall
bias and reporting error. However, recent reports
suggest high self-reported stroke accuracy, even in
the disabled elderly, with sensitivity rates ranging
from 80% to 98%37,38 and substantial reliability in
minorities.39 We were unable to assess the effect of
acculturation or English proficiency among Hispan-
ics but decreased acculturation and limited English
proficiency are associated with lower rates of receipt
of recommended health care services.40 Because the
NHIS does not have measures of disease severity, the
comorbidity score did not incorporate disease sever-
ity. The NHIS includes only community-dwelling,
noninstitutionalized stroke survivors, and results
may only be generalized to this population. Selection
bias may occur if minority stroke survivors with re-
duced access to care are less frequently sampled com-
pared to minority stroke survivors with adequate
access. This potential selection bias would reduce the
ability to detect the differences we observed. Further
research is needed to assess whether disparities in
these processes of care are associated with racial/
ethnic differences in poststroke outcomes such as re-
current stroke.
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